Knowing stock market today at a glance

Avanos Medical Soars 6.11% on CEO Transition

Mover TrackerMonday, Apr 21, 2025 4:46 am ET

1min read

Avanos Medical's stock surged 6.11% in pre-market trading on April 21, 2025, marking a significant rise in investor confidence.

Avanos Medical has recently undergone notable leadership changes. On April 18, 2025, Michael C. Greiner announced his departure from the company to pursue other opportunities. Greiner had been serving as the Interim Chief Executive Officer since October 28, 2024, and previously held the positions of Senior Vice President and Chief Financial Officer since 2020, and Chief Transformation Officer since 2023. His decision to leave came after the company did not offer him a position comparable to his previous role. Despite his departure, Greiner will remain with the company in a consulting capacity until May 16, 2025.

Following Greiner's departure, avanos medical appointed David Pacitti as its new Chief Executive Officer. This leadership change is expected to bring fresh perspectives and strategic direction to the company, potentially influencing its future performance and investor sentiment.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.